Literature DB >> 20356826

NMR characterization and molecular modeling of fucoidan showing the importance of oligosaccharide branching in its anticomplementary activity.

Marie-Jeanne Clément1, Bérangère Tissot, Lionel Chevolot, Elisabeth Adjadj, Yuguo Du, Patrick A Curmi, Régis Daniel.   

Abstract

Fucoidan is a potent inhibitor of the human complement system whose activity is mediated through interactions with certain proteins belonging to the classical pathway, particularly the protein C4. Branched fucoidan oligosaccharides displayed a higher anticomplementary activity as compared to linear structures. Nuclear magnetic resonance (NMR) characterization of the branched oligosaccharides and saturation transfer difference-NMR experiment of the interaction with the protein C4 allowed the identification of the glycan residues in close contact with the target protein. Transferred nuclear Overhauser effect spectroscopy experiment and molecular modeling of fucoidan oligosaccharides indicated that the presence of side chains reduces the flexibility of the oligosaccharide backbone, which thus adopts a conformation which is very close to the one recognized by the protein C4. Together, these results suggest that branching of fucoidan oligosaccharides, determining their conformational state, has a major impact on their anticomplementary activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20356826     DOI: 10.1093/glycob/cwq046

Source DB:  PubMed          Journal:  Glycobiology        ISSN: 0959-6658            Impact factor:   4.313


  11 in total

1.  Complementarity of Raman and Infrared spectroscopy for rapid characterization of fucoidan extracts.

Authors:  Signe H Ptak; Lee Sanchez; Xavier Fretté; Dmitry Kurouski
Journal:  Plant Methods       Date:  2021-12-20       Impact factor: 4.993

Review 2.  Chemical structures and bioactivities of sulfated polysaccharides from marine algae.

Authors:  Guangling Jiao; Guangli Yu; Junzeng Zhang; H Stephen Ewart
Journal:  Mar Drugs       Date:  2011-02-08       Impact factor: 6.085

Review 3.  Therapies from fucoidan; multifunctional marine polymers.

Authors:  Janet Helen Fitton
Journal:  Mar Drugs       Date:  2011-09-30       Impact factor: 6.085

4.  Structural analysis and anti-complement activity of polysaccharides from Kjellmaniella crsaaifolia.

Authors:  Wenjing Zhang; Weihua Jin; Delin Sun; Luyu Zhao; Jing Wang; Delin Duan; Quanbin Zhang
Journal:  Mar Drugs       Date:  2015-03-16       Impact factor: 5.118

Review 5.  Marine polysaccharides from algae with potential biomedical applications.

Authors:  Maria Filomena de Jesus Raposo; Alcina Maria Bernardo de Morais; Rui Manuel Santos Costa de Morais
Journal:  Mar Drugs       Date:  2015-05-15       Impact factor: 5.118

6.  Fucoidan from Fucus vesiculosus protects against alcohol-induced liver damage by modulating inflammatory mediators in mice and HepG2 cells.

Authors:  Jung Dae Lim; Sung Ryul Lee; Taeseong Kim; Seon-A Jang; Se Chan Kang; Hyun Jung Koo; Eunsoo Sohn; Jong Phil Bak; Seung Namkoong; Hyoung Kyu Kim; In Sung Song; Nari Kim; Eun-Hwa Sohn; Jin Han
Journal:  Mar Drugs       Date:  2015-02-16       Impact factor: 5.118

7.  The Structure-Activity Relationship between Marine Algae Polysaccharides and Anti-Complement Activity.

Authors:  Weihua Jin; Wenjing Zhang; Hongze Liang; Quanbin Zhang
Journal:  Mar Drugs       Date:  2015-12-25       Impact factor: 5.118

8.  Pharmaceutical Development and Safety Evaluation of a GMP-Grade Fucoidan for Molecular Diagnosis of Cardiovascular Diseases.

Authors:  Cédric Chauvierre; Rachida Aid-Launais; Joël Aerts; Frédéric Chaubet; Murielle Maire; Lucas Chollet; Lydia Rolland; Roberta Bonafé; Silvia Rossi; Simona Bussi; Claudia Cabella; Laszlo Dézsi; Tamas Fülöp; Janos Szebeni; Youssef Chahid; Kang H Zheng; Erik S G Stroes; Dominique Le Guludec; François Rouzet; Didier Letourneur
Journal:  Mar Drugs       Date:  2019-12-12       Impact factor: 5.118

9.  Comparison of edible brown algae extracts for the inhibition of intestinal carbohydrate digestive enzymes involved in glucose release from the diet.

Authors:  Maha Attjioui; Sinead Ryan; Aleksandra Konic Ristic; Thomas Higgins; Oscar Goñi; Eileen R Gibney; Joanna Tierney; Shane O'Connell
Journal:  J Nutr Sci       Date:  2021-01-12

Review 10.  Therapies from Fucoidan: An Update.

Authors:  Janet Helen Fitton; Damien N Stringer; Samuel S Karpiniec
Journal:  Mar Drugs       Date:  2015-09-16       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.